The Fed’s regulatory chief recently weighed in on a path to improvement following a string of midsize bank failures. Eli Lilly’s Retatrutide medication was recently under the WSJ spotlight for its surprising results. Rite Aid’s stock just hit a record low. We’re discussing these topics and more in Episode 11.


------🔎RESOURCES🔎

CPI REPORT // https://www.bls.gov/news.release/pdf/cpi.pdf

ADP JOBS REPORT // https://adpemploymentreport.com/

JOLTS REPORT // https://www.bls.gov/news.release/jolts.nr0.htm

REDBOOK RETAIL REPORT // https://tradingeconomics.com/united-states/redbook-index

BANKS ARE GOING TO NEED MORE CAPITAL (WSJ) // https://on.wsj.com/3pNXG5e

LILLY'S RETATRUTIDE SHOWS BENEFITS ON FATTY LIVER DISEASE (WSJ) // https://bit.ly/3XRDyLX

RITE-AID DEBT CONCERNS (MARKETWATCH) // https://bit.ly/3rAYlas

MARCUS WHITNEY: BANKING STRUGGLES ARE LIMITING HEALTHCARE INNOVATION (HFMA) // https://bit.ly/44J4gZo


------🔔SIGN UP FOR EPISODE NOTIFICATIONS🔔 https://www.podpage.com/healthfurther/


------📱FOLLOW HEALTH:FURTHER SOCIALS📱

INSTAGRAM // https://www.instagram.com/healthfurther/

TWITTER // https://twitter.com/HealthFurther

FACEBOOK // https://www.facebook.com/HealthFurther/

LINKEDIN // https://www.linkedin.com/company/health-further

TIKTOK // https://www.tiktok.com/@healthfurther

YOUTUBE // https://www.youtube.com/channel/UCFM4torjTIEkOLOD-p7FIKw

HF Site

YOUTUBE
INSTAGRAM
TWITTER
FACEBOOK
LINKEDIN
TIKTOK